percentage of us population on glp 1 Products - Data Briefs - Number 537 KFF Health Tracking Poll May

To illustrate these interactions, Figure 2 is presented below, and highlights points of convergence between underexplored peptides and established incretin pathways

Also note that abruptly stopping GLP-1 medication is not recommended

Expanding applications: GLP-1s are now being explored beyond metabolic diseases, including liver disease (e.g., MASH/NAFLD), cardiovascular health, sleep apnea, alcohol use disorder, and potentially reducing obesity-related cancer risk

Shirakawa J, Fujii H, Ohnuma K, Sato K, Ito Y, Kaji M, Sakamoto E, Koganei M, Sasaki H, Nagashima Y, et al

Furthermore, emerging research suggests GLP-1 receptors exist in the brain, heart, and immune cells

Low iron can restrict oxygen supply to hair follicles, leading to thinning and shedding